The CXCR4 antagonist AMD3100 mobilizes a more primitive subset of CD34+cells than G-CSF

被引：0
|
作者：
Seeger, T
Veldwijk, M
Bridger, G
Calandra, G
Goldschmidt, H
Ho, A
Fruehauf, S
机构：
[1] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[2] German Canc Res Ctr, Dept E0120, D-6900 Heidelberg, Germany
[3] AnorMED, Langley, BC, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.1969.1969
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1969
引用
收藏
页码：558A / 558A
页数：1
相关论文
共 50 条
  • [41] Amd 3100 successfully mobilizes autologous CD34+cells after failure of G-CSF mobilization regimens with low toxicity and acceptable autologous stem cell transplant (ASCT) outcomes
    Shaughnessy, P. J.
    Hougham, M.
    Bachier, C.
    LeMaistre, C. F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 79 - 79
  • [42] The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level
    Princen, K
    Hatse, S
    Vermeire, K
    Bridger, GJ
    Skerlj, RT
    De Clercq, E
    Schols, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (12) : 1135 - 1139
  • [43] CXCR4 Antagonist AMD3100 Modulates Claudin Expression and Intestinal Barrier Function in Experimental Colitis
    Xia, Xian-Ming
    Wang, Fang-Yu
    Zhou, Ju
    Hu, Kai-Feng
    Li, Su-Wen
    Zou, Bing-Bing
    PLOS ONE, 2011, 6 (11):
  • [44] Treatment with the CXCR4 Antagonist AMD3100 Enhances Antibody Mediated Killing in Disseminated Lymphoma Models
    Siders, William
    Hu, Yanping
    Gale, Matthew
    Jacques, Gary
    Fogle, Robert
    Shields, Jacqueline
    Garron, Carrie
    Kaplan, Johanne
    BLOOD, 2009, 114 (22) : 1064 - 1064
  • [45] Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma
    Regenbogen, Stephan
    Stagno, Matias Julian
    Schleicher, Sabine
    Schilbach, Karin
    Boesmueller, Hans
    Fuchs, Joerg
    Schmid, Evi
    Seitz, Guido
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (01) : 289 - 300
  • [46] Mobilization of bone marrow stem/progenitor cells by AMD3100 or G-CSF is impaired in diabetes
    Vasam, Goutham
    Bartelmez, Stephen
    Jarajapu, Yagna
    FASEB JOURNAL, 2014, 28 (01):
  • [47] AMD3100 and G-CSF for poor mobilisers; successful harvest of stem cells in a child with cancer
    Bateman, CM
    Stephen, K
    Calandra, G
    Shaw, PJ
    BONE MARROW TRANSPLANTATION, 2005, 35 : S105 - S105
  • [48] Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers
    De Clercq, Erik
    PHARMACOLOGY & THERAPEUTICS, 2010, 128 (03) : 509 - 518
  • [49] The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV. Coreceptor expression level
    Princen, K
    Hatse, S
    Vermeire, K
    Bridger, GJ
    Skerlj, RT
    De Clercq, E
    Schols, D
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A52 - A52
  • [50] CXCR4 Antagonist AMD3100 Preserves Cardiac Function After Myocardial Infarction (MI) via CXCR4 Dependent and Independent Pathways
    Jujo, Kentaro
    Hamada, Hiromichi
    Seguchi, Haruki
    Thorne, Tina
    Klyachko, Ekaterina
    Renault, Marie-Ange
    Losordo, Douglas W.
    CIRCULATION, 2009, 120 (18) : S1041 - S1042
12345